Integris Cancer Institute of Oklahoma — Oklahoma City, Oklahoma

Integris Cancer Institute of Oklahoma is a clinical research site located in Oklahoma City, Oklahoma, United States 73142.

Crixeo Clinical Trials Trust Score: 25/100 (FAILING). This profile has not yet been claimed by the site owner.

Integris Cancer Institute of Oklahoma has participated in 37 clinical trials with 23 currently active.

Therapeutic areas: Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, SWOG Cancer Research Network.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Oklahoma City

Browse all research sites in Oklahoma · View every site in Oklahoma City

• University of Oklahoma Health Sciences Center Dept of OB/GYN
• University of Oklahoma Health Sciences Center Dept. of Oklahoma Univ. HSC
• University of Oklahoma/ Health Science
• Bone and Joint Hospital at St. Anthony Research Department
• University Health Science Center/Cardio Section
• Stephenson Cancer Center - Oklahoma University
• St. Anthony Hospital - Conference Rooms
• Mercy Hospital Oklahoma City - Mercy Coletta Cancer Center - Oklahoma City
• University of Oklahoma Health Sciences Center - HPRC
• University of Oklahoma
• OU Medical Center Hospital
• University of Oklahoma - Department of Pharmacy Practice

Sponsor Feasibility Report

Trust Score: 25/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Integris Cancer Institute of Oklahoma?

Integris Cancer Institute of Oklahoma has a Crixeo Trust Score of 25/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Integris Cancer Institute of Oklahoma conducted?

Integris Cancer Institute of Oklahoma has 37 clinical trials on record, with 23 currently active. Their work covers Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma.

Is Integris Cancer Institute of Oklahoma accredited by Crixeo Clinical Trials?

Integris Cancer Institute of Oklahoma has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Integris Cancer Institute of Oklahoma?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.